Category: Research Compliance

Posted on May 30, 2012 by |
From OLAW: Join us for a webinar: “Grants Policy and Congruence” on June 7, 2012 at 1:00 PM ET. Dr. Patricia Brown, OLAW Director, will discuss the requirements for assuring congruence between grant applications and what the IACUC has approved…
Read more »

Posted on May 11, 2012 by |
A clinical investigator in Florida suggests that clinical trial simulators could someday replace trials with real participants – at least to some extent. In an interview with MedCity News, Dr. Michael Smith explained that supercomputers could be used to conduct…
Read more »

Posted on May 8, 2012 by |
We’ve fielded this question during several recent product demonstrations and other interactions with prospective clients. The answer is, absolutely! The InfoEd Human Subjects module can support virtually any type of IRB review, including both biomedical and SBR models. Flexible administrative…
Read more »

Posted on May 8, 2012 by |
How do you make sure that your scientific/assigned reviewers are really reviewing their assigned protocols?  Do you ask that your assigned reviewers answer questions or think about certain regulations for compliance review during their efforts?  Candy and chocolates do not…
Read more »

Posted on May 7, 2012 by |
The Congressional Research Service has released a report entitled, “Nanotechnology: A Policy Primer“.  Detailed within are current areas of nanotechnology product research and development (with examples from private and public research) and funding for these programs.  The funding levels by fiscal year…
Read more »

Posted on April 30, 2012 by |
The FDA has approved Levaquin (levofloxacin)(Johnson & Johnson’s) for the treatment of  pneumonic plague (caused by Yersinia pestis).   A member of the fluoroquinolone family of drugs, it is currently approved for treatment of numerous infections, including post-inhalation Anthrax exposure.  The approval was…
Read more »